Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
{{output}}
Immunosuppressive agents are the standard therapeutic approach for immune thrombocy-topenia (ITP). Their prolonged use may increase the risk of infectious complications, particularly when the patient is already at higher infectious risk. In this setting, the u... ...
